Who Paid My Doc
Melissa Herst
Registered Nurse, Psychiatric/Mental Health Vinita, OK Nurse Practitioner
NPI 1235840570 CMS profile 11401073
405 E Excelsior Ave, Vinita, OK 74301
General payments
$103
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Melissa Herst of Vinita, OK is reported in the CMS Open Payments database as having received $103 across 6 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 40th percentile of Registered Nurse, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $103 | 6 |
Beside peers
- Melissa Herst
- Registered Nurse, Psychiatric/Mental Health median
- Middle half of Registered Nurse, Psychiatric/Mental Health
- National median
In program year 2025, general payments to Melissa Herst were reported at $0. Among 280 Registered Nurse, Psychiatric/Mental Health profiles paid that year, the median was $140 and the middle half received between $43 and $515.
Show as a table
| Year | Melissa Herst | Registered Nurse, Psychiatric/Mental Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $101 | $31–$244 | $132 |
| 2022 | $0 | $103 | $36–$248 | $149 |
| 2023 | $103 | $138 | $45–$382 | $160 |
| 2024 | $0 | $167 | $39–$462 | $164 |
| 2025 | $0 | $140 | $43–$515 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 24 drugsPart D claims
630
Drug cost
$69,870
Branded share of claims
11%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Invega Sustenna Paliperidone Palmitate | Brand | 15 | $52,433 | |
| Chlorpromazine Hcl | Generic | 37 | $7,995 | |
| Paliperidone Er Paliperidone | Brand | 15 | $1,718 | |
| Olanzapine | Generic | 87 | $1,143 | |
| Doxepin Hcl | Generic | 38 | $832 | |
| Haloperidol | Generic | 16 | $777 | |
| Fluoxetine Hcl | Generic | 57 | $600 | |
| Prazosin Hcl | Generic | 31 | $568 | |
| Aripiprazole | Generic | 35 | $551 | |
| Amantadine Amantadine Hcl | Brand | 15 | $504 |
The 10 drugs with the highest cost, of 24 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 476 Part D prescribers listed as Registered Nurse; they describe a distribution and say nothing about conduct.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Registered Nurse, Psychiatric/Mental Health in Oklahoma
Related records
Registered Nurse, Psychiatric/Mental Health in Oklahoma
Practitioners in the same specialty and state, ranked by reported value.
All Registered Nurse, Psychiatric/Mental Health
Everyone recorded under this specialty, nationwide.
Doctors in Oklahoma
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.